Small-cell neuroendocrine carcinoma displays unique profiles of tumor-suppressor gene loss in relationship to the primary site of formation.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 12378519)

Published in Hum Pathol on September 01, 2002

Authors

Sanja Dacic1, Sydney D Finkelstein, Fabien K Baksh, Patricia A Swalsky, Leon E Barnes, Samuel A Yousem

Author Affiliations

1: Department of Pathology, Division of Anatomic Pathology, University of Pittsburgh Medical Center, Presbyterian University Hospital, PA 15213, USA.

Articles by these authors

Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90

Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc (2009) 3.32

A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med (2006) 3.16

Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 3.02

Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 2.43

Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. J Neurosurg (2006) 1.93

Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile. Am J Clin Pathol (2009) 1.86

Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol (2006) 1.84

Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med (2002) 1.74

ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res (2003) 1.71

Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant (2013) 1.71

The development and testing of a laboratory information system-driven tool for pre-sign-out quality assurance of random surgical pathology reports. Am J Clin Pathol (2010) 1.50

HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46

Comparative mutational profiling in the assessment of lung lesions: should it be the standard of care? Ann Thorac Surg (2010) 1.44

Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Am J Clin Pathol (2006) 1.34

HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27

Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. J Surg Res (2011) 1.20

Mucoepidermoid carcinoma: a five-decade journey. Virchows Arch (2011) 1.18

Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery (2002) 1.12

Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol (2002) 1.11

Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer. Cancer Res (2002) 1.09

Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol (2005) 1.08

Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population. Am J Clin Pathol (2011) 1.08

Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl (2003) 1.08

Neoadjuvant imatinib in gastrointestinal stromal tumor of the rectum: report of a case. Dis Colon Rectum (2005) 1.07

Inflammatory fibroid polyps of the gastrointestinal tract: clinical, pathologic, and molecular characteristics. Appl Immunohistochem Mol Morphol (2004) 1.06

K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Diagn Cytopathol (2006) 1.04

Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology (2003) 1.03

Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. Hum Pathol (2009) 0.99

DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation (2002) 0.99

A microdissection and molecular genotyping assay to confirm the identity of tissue floaters in paraffin-embedded tissue blocks. Arch Pathol Lab Med (2003) 0.98

Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma. Mod Pathol (2008) 0.97

Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans. Am J Respir Crit Care Med (2012) 0.97

Microdissection techniques for molecular testing in surgical pathology. Arch Pathol Lab Med (2004) 0.97

Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort. Pediatr Neurosurg (2003) 0.96

Histologic classification of idiopathic chronic interstitial pneumonias. Am J Respir Cell Mol Biol (2003) 0.95

Jejunal gastrointestinal stromal tumor: a cause of obscure gastrointestinal bleeding. Arch Pathol Lab Med (2004) 0.92

Osteoclast-type giant cell neoplasm of salivary gland. A microdissection-based comparative genotyping assay and literature review: extraskeletal "giant cell tumor of bone" or osteoclast-type giant cell "carcinoma"? Am J Surg Pathol (2004) 0.92

Pathobiology of severe asthma. Annu Rev Pathol (2014) 0.91

A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res (2006) 0.91

Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol (2003) 0.90

Molecular analysis of multifocal papillary thyroid carcinoma. J Mol Endocrinol (2008) 0.90

Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma. Mod Pathol (2003) 0.90

Webcasting pathology department conferences in a geographically distributed medical center. Hum Pathol (2004) 0.89

Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix. Ann Surg Oncol (2006) 0.89

Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer. Ann Thorac Surg (2011) 0.89

Initial experience with a novel pre-sign-out quality assurance tool for review of random surgical pathology diagnoses in a subspecialty-based university practice. Am J Surg Pathol (2010) 0.89

Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res (2002) 0.88

Asthmatic granulomatosis: a novel disease with asthmatic and granulomatous features. Am J Respir Crit Care Med (2012) 0.87

Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature. Mod Pathol (2004) 0.87

Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis. Arch Pathol Lab Med (2004) 0.87

Molecular staging of lymph nodes from patients with esophageal adenocarcinoma. Clin Cancer Res (2005) 0.87

Antibody-mediated rejection in lung transplantation: case reports. Clin Transpl (2006) 0.87

Absence of Mycobacterium avium subsp. paratuberculosis in the microdissected granulomas of Crohn's disease. Mod Pathol (2004) 0.86

Multiple loss of heterozygosity without K-ras mutation identified by molecular analysis on fine-needle aspiration cytology specimen of acinar cell carcinoma of pancreas. Diagn Cytopathol (2002) 0.86

Granular cell astrocytomas show a high frequency of allelic loss but are not a genetically defined subset. Brain Pathol (2003) 0.86

Microdissection-based mutational genotyping of serous borderline tumors of the ovary. Int J Gynecol Pathol (2005) 0.85

Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy. Cancer (2009) 0.84

Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. Endocr Pathol (2002) 0.84

Gross cystic disease fluid protein-(GCDFP-15): expression in primary lung adenocarcinoma. Am J Surg Pathol (2008) 0.84

Abdominal mucinous cystic neoplasm in a male child. Pediatr Dev Pathol (2008) 0.84

Microdissection-based allelotyping: a novel technique to determine the temporal sequence and biological aggressiveness of colorectal cancer. Am Surg (2006) 0.82

Loss of heterozygosity reveals non-VHL allelic loss in hemangioblastomas at 22q13. Hum Pathol (2004) 0.82

Pulmonary meningothelial-like nodules: a genotypic comparison with meningiomas. Am J Surg Pathol (2004) 0.82

EUS-guided pancreatic fluid aspiration for DNA analysis of KRAS and GNAS mutations for the evaluation of pancreatic cystic neoplasia: a pilot study. Gastrointest Endosc (2013) 0.81

Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts. Transplantation (2008) 0.81

Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol (2006) 0.81

Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma. Liver Transpl (2008) 0.81

Determination of sequential mutation accumulation in pancreas and bile duct brushing cytology. Mod Pathol (2006) 0.81

Nonspecific interstitial pneumonia: a study of 6 patients with progressive disease. Am J Surg Pathol (2012) 0.80

In vivo expression of p53 and Bcl-2 and their role in programmed cell death in premalignant and malignant lung lesions. Lung Cancer (2002) 0.80

A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness. Hum Pathol (2003) 0.79

Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors. Surgery (2003) 0.79

Analysis of loss of heterozygosity in atypical and negative bile duct brushing cytology specimens with malignant outcome: are "false-negative" cytologic findings a representation of morphologically subtle molecular alterations? Arch Pathol Lab Med (2007) 0.78

Molecular profiling of primary and metastatic neoplasms in the lung using cytologic material obtained by fine-needle aspiration: report of two cases. Diagn Cytopathol (2004) 0.78

Microscopic papillary thyroid carcinoma compared with clinical carcinomas by loss of heterozygosity mutational profile. Am J Surg Pathol (2003) 0.78

Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer. J Thorac Cardiovasc Surg (2002) 0.78

Role of liver transplantation for hepatobiliary malignant disorders. Lancet Oncol (2004) 0.78

Frozen section diagnosis: is there discordance between what pathologists say and what surgeons hear? Am J Clin Pathol (2013) 0.77

Advancing the diagnosis and treatment of hepatocellular carcinoma. Liver Transpl (2005) 0.77